DatasetName,CANX_S(446) CANX_S(456) CANX_S(475) CANX_S(551) CANX_S(553) CANX_S(554) CANX_S(564) CANX_S(583) CANX_S(589) CANX_S(599) CANX_S(618) CANX_T(551) CANX_T(562) CANX_T(597) CANX_T(93) CANX_Y(514) CANX_Y(70),CANX_S(10) CANX_S(11) CANX_S(3) CANX_T(171) CANX_T(542) CANX_T(553),CANX_S(534) CANX_S(544) CANX_S(563) CANX_T(128)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,0.5566106307148646,,
FSO2013_Ratio M/L normalized Rep3,0.5531681207577641,,
SR2019_MCF7_Biol_repl_3,0.5698691182275396,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,0.5558553080388651,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,0.5889352542953883,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,,,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,0.5590554784536516,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,0.5708764669769667,,
ZX2022_Control Replicate 2,0.5512346667709247,,
HS2024_6_B_T3,,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,0.5522987630278144,,
FSO2013_Ratio M/L normalized Rep1,0.5553037427969612,,
SR2019_MDAMB231_Biol_repl_4,0.5569326224201882,,
GF2025_P2_Sph,0.5290146826842824,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,,,0.7499009333412263
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,0.5634050523130941,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,0.5586874660156493,,
HS2024_7_B_N1,,,
FSO2013_Ratio M/L normalized Rep1___1,0.5553109235231806,,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,,,
RB2022_5_PreEndurance,0.5474553956622606,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,0.5802220951631153,,
WZ2023_Pu_010_30min,0.5982356676423217,,
AS2011_Ratio H/L Proteins RNAi_2,0.5573095535638138,,
RB2022_4_PreStrength,0.547205680931208,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,,,
RB2022_8_RecoveryEndurance,0.5587015648243193,,
KBE2022_Log2_Ex_14_U,,0.3883748821626914,0.7469251601151499
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,,,
JJ2018_Ratio H/L normalized___1,0.5460424422692632,,
ZQ2022_C2,0.5484461007022636,,
RB2022_5_PreSprint,0.5507278673961976,,
PG2020_Intensity 8h_C,0.568360521872273,,
AH2018_SILAC_MR_2_N,,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,0.5279586850842743,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,0.5431355843163826,,
AS2011_Ratio H/L Proteins Inhi_2,0.5495904022395045,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,0.6037900722378268,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5320678393821636,,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,0.5465567276537423,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,0.5583225866926441,,
GF2025_P6_Sph,0.5498794968316031,,
RB2022_2_PreSprint,0.5355364809166833,,
ZX2022_CB treated Replicate 3,0.550467886688789,,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.5964922639162833,,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,0.5632423824465757,,
KBE2022_Log2_Ex_34_U,,,0.7556883945012411
WZ2023_Pu_005_10min,0.6004921025757983,,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,0.5908509336700466,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,0.5557704642404097,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.602052988297934,,
AH2018_SILAC_MR_2_X,,,
HS2024_4_PD_T2,,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,0.5423195226489446,,
AS2011_Ratio H/L Protein RNAi_1,0.5630634038808562,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,0.5526114113682487,,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,,,
EJN2021_3_Rest_Basal,0.5755654079369157,0.3995514165072778,
CR2017_Ratio Replicate 1.3,0.5579056961394586,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,0.5492000689737121,,
AMK2021_120R_p1,0.5571409638854642,,
AH2018_SILAC_3_X,,,
JJ2018_Ratio M/L normalized pP3,0.5483477196381419,,
AH2018_SILAC_M_2_N,,,
HS2024_7_PD_T2,,,
FSO2013_Ratio H/L normalized Rep1___1,0.5392452506999003,,
AH2018_LFQ_1_C,,,
AS2011_Ratio H/L Normalized Inhi_1_3,0.5314546472633882,,
KBE2022_Log2_Ex_28_T,,,0.7442090731686316
HS2024_3_B_N1,,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.5978810056067975,,
CK2022_11 40-1,0.5902162356026646,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,0.5562764257060803,,
AH2018_SILAC_2_X,,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,,,
FSO2013_Ratio H/L normalized Rep2,0.5527521993524386,,
WZ2023_Pu_005_20min,0.5977076306923659,,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,0.5510467029185765,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,0.5534999239504457,,
HS2024_7_B_T3,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,0.5459287911029364,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,0.5529608793270653,,
HS2024_9_B_T2,,,
KTGR2014_Ratio-AA 7 mins,0.5491357343392028,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,,
FSO2013_Ratio M/L normalized Rep3___2,,,
SR2019_BT549_Biol_repl_3,0.5605653374325109,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,0.5457635593989665,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,0.5575331669201599,,
CK2022_1 16-1,0.5898576805911344,,
CK2022_1 200-1,0.6106939015628114,,
PG2020_Intensity Mock_10h_D,0.5583046203922722,,
SR2019_MCF10A_Biol_repl_2,0.5627600522874856,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,0.5798091385002914,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5329174879704266,,
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,0.5741243321384687,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,0.5300931752625369,,
PG2020_Intensity 2h_C,0.5695155185225891,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,0.5471568500814578,,
KBE2022_Log2_Ex_8_T,,0.3921132018420063,0.7597572803263495
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,,
RN2012_L11,0.5208690705704262,,
AS2011_Ratio H/L Normalized Inhi_2_2,0.5490889202296284,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,,,
AH2018_LFQ_M_2_C,,,
CK2022_3 40-1,0.5914172508376774,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,,,
YA2020_Reporter_intensity_Cancer_No.5,,,
HH2022_Reporter intensity 8,0.564024814098182,,
ZQ2022_N2,0.5504344470256366,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,0.5496597296302737,,
EJN2021_5_Rest_Basal,0.5707844525281061,0.40230751175749613,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,0.5614222255127364,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,0.5361238817160311,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,,,
YA2020_Reporter_intensity_Normal_No.1,,,
HS2024_3_B_T1,,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,,
RB2022_1_PostEndurance,0.5532233679420769,,
CR2017_Ratio Replicate 3,0.5474390748477691,,
SR2019_Hs578T_Biol_repl_3,0.5678908472721621,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,0.5566506356838408,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,0.5532317094589686,,
GF2025_P7_Sph,0.5507874541939652,,
HS2024_8_I_T3,,,
CF2017_EOC 3,0.620137141088364,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,0.5544445001244542,,
HS2024_6_PD_T3,,,
DL2023_12h-2,0.570104296339718,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.6021961921044429,,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,0.5920187705377954,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,0.5553509271941126,,
CK2022_8 16-1,0.5897807039661513,,
KS2014_Intensity N3,,,
RB2022_4_RecoveryEndurance,0.5470939315045256,,
RB2022_5_RecoveryEndurance,,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,,,
FSO2013_Ratio H/M normalized Rep2,0.55077944057486,,
RAM2015_Log2 A,0.5614895590750568,,
HS2024_8_PD_T1,,,
JJ2018_Ratio H/L normalized pP2,0.5531579901276916,,
CF2017_OSE 27,0.6043554804634301,,
KS2014_Intensity E15_2,,,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,0.5752363149114298,,
HS2024_7_I_T1,,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,0.5685470846754905,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,,
AH2018_SILAC_M_3_X,,,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,0.5434437721796465,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,,,0.7352209663440128
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),0.5726560060620391,,
RB2022_8_PostEndurance,0.5510575442197273,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,0.5625203783081801,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,0.5805589845411301,,
HS2024_6_B_N1,,,
KBE2022_Log2_Ex_27_T,,0.40381408973667426,0.7643961300541721
CW2012_10 µM Gef/control Experiment 1 Replicate A,0.5543934076098591,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,0.556256183007538,,
AS2011_Ratio H/L Proteins,0.5520719761582685,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.3991009506654517,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,,,
AH2018_SILAC_IT_3_X,,,
JAW2011_Ratio H/L,0.5606432422823202,,
PG2020_Intensity 10h_C,0.5714884722601883,,
FSO2013_Ratio M/L normalized Rep2,0.5549208127470072,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,0.5644455101887054,0.3958599256409638,
SR2019_HCC1954_Biol_repl_2,0.5503108050669363,,
CK2022_14 40-1,0.5716280843543625,,
RB2022_6_PreSprint,0.5509770738806695,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,0.5822588705993109,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,,
DL2023_control-1,0.5726568991341797,,
AR2021_ALG 10 μM,0.5402067006039857,,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,,,
EJN2021_4_Rest_Ins,0.5718169689721537,0.3983198268820857,
RN2012_H05,0.5442572287092682,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,0.5633935579460638,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,,
EJN2021_1_Rest_Ins,0.5727982521639831,0.39651560837320665,
HH2022_Reporter intensity 3,0.5564086122537936,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,,,
JW2021_After_3,0.5690001728365106,,
GF2025_P8_Sph,0.562902045666991,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,0.5506075942192418,,
AH2018_SILAC_2_N,,,
CK2022_11 200-1,0.6120704747343004,,
CK2022_12 200-1,0.6028037274367997,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,0.5628861779759228,0.4037375804444934,
WZ2023_Su_010_20min,0.6001079934675064,,
AH2018_TMTMS2_2_N,0.5499674408368049,,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,,,0.7485322567136476
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.39421845940191397,
AH2018_TMTMS3_Pool,0.5515044918944906,,
KS2014_Intensity N4,,,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,0.55992967626811,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,0.6064443945806125,,
CK2022_14 200-1,0.5939991409030527,,
SR2019_Hs578T_Biol_repl_1,0.5627050221386354,,
RB2022_7_PostSprint,0.5452208068540011,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,0.5519950879939932,,
AST2020_anti-CD3+PDL2.2,0.5630149298049044,,
PG2020_Intensity Mock_10h_A,0.5634777225440173,,
JW2021_After_2,0.5554646681261572,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,0.5698622462489731,0.3991525908278503,
SR2019_LM2_Biol_repl_4,0.5549899593203225,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,0.5610078864979843,,
CK2022_13 16-1,0.5725092824412911,,
GF2025_P1_Adh,0.5473176703050326,,
GF2025_P1_Sph,0.5416105744376122,,
EJN2021_5_Ex_Basal,0.5755790088726171,0.3913931642437039,
HS2024_7_I_T3,,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.5972828703053081,,
CF2017_EOC 1,0.602570772246974,,
CK2022_3 200-1,0.611607449366533,,
AH2018_LFQ_IT_3_C,,,
SR2019_Hs578T_Biol_repl_2,0.5611905940816189,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,,,
HS2024_5_B_T1,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,0.5538163148040245,,
DL2023_12h-3,0.5713759020320778,,
SR2019_MDAMB231_Biol_repl_2,0.554082805859595,,
HS2024_3_B_T2,,,
RB2022_6_PreStrength,0.5355628218128117,,
CK2022_2 40-1,0.5922363480589012,,
RB2022_1_PostSprint,,,
CK2022_4 200-1,0.6101674913288013,,
JW2021_Before_2,0.558625229914669,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,0.5897768748881499,,
AR2021_ALG 1 μM,0.5717265268546212,,
HS2024_4_B_T1,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,0.5603276601652998,,
EJN2021_1_Rest_Basal,0.5754773510789258,0.4049033093282353,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,0.5587519616376992,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,0.576053277157463,,
CK2022_9 16-1,0.5915624679263783,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,0.5530190982584654,,
AS2011_Ratio H/L Normalized RNAi_2,0.5517702245499577,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,0.593614446519339,,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,0.5660705073026341,,
CK2022_16 16-1,0.5699554415510237,,
FS2019_db/db3,,,
CK2022_15 40-1,0.5702694394972729,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.5958862184153552,,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),0.565865893050282,,
KBE2022_Log2_Ex_41_T,,,0.7579401890824109
AMK2021_Ctrl_p1,0.5584164718545153,,
AH2018_LFQ_IT_3_X,,,
HS2024_5_PD_T3,,,
AH2018_TMTMS3_3_X,0.5503361131682433,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,,0.3961907660521294,0.748082505064953
AH2018_LFQ_M_1_N,,,
KBE2022_Log2_Ex_27_U,,0.4066062630738088,0.7589040779432898
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,,,
YA2020_Reporter_intensity_Normal_No.4,,,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,0.5660256236091509,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,0.5805057143826899,,
RN2012_L13,0.5808198273061724,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,,0.3933612185698501,0.7510481357368279
SR2019_SKBR3_Biol_repl_3,0.551269324722651,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,0.563248692707572,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,0.5535533616835834,,
AS2011_Ratio H/L Protein Inhi_1,0.5198694498092145,,
FSO2013_Ratio H/M normalized Rep2___1,0.5524497880074497,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,0.595240290184778,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,0.5553431873093281,,
HH2022_Reporter intensity 6,0.5639626100341105,0.39619604934222646,
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,0.5508072236363473,,
AS2011_Ratio H/L Normalized RNAi_2_2,0.5592717778818426,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,0.5280635588782499,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,0.5536829841798864,,
AH2018_TMTMS2_3_X,0.5491762629632692,,
GF2025_P3_Adh,0.5416267053973726,,
SR2019_JIMT1_Biol_repl_2,0.5807925163985581,,
AH2018_TMTMS2_1_C,0.5515688518200447,,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,0.5127914716551584,,
KBE2022_Log2_Ex_19_U,,0.4038386273825089,0.7599660816855842
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,,,
AST2020_Control,0.5631508389683068,,
JAW2011_Ratio H/L LS1a,0.5615995747447742,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,0.5314546472633882,,
FSO2013_Ratio M/L normalized Rep2___1,0.5546938828792135,,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,0.5504967223077527,,
RB2022_7_RecoverySprint,0.5536697230398977,,
YA2020_Reporter_intensity_Normal_No.3,,,
HS2024_8_B_T2,,,
AH2018_LFQ_1_X,,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,,,
HH2022_Reporter intensity 1,0.5581205389840057,0.39596813775162215,
HH2022_Reporter intensity 2,0.5572739087542128,0.3961468807243445,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,,,
SR2019_MCF7_Biol_repl_1,0.5698595661607321,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,0.556265967773836,,
EP2017_Untreated R#2 log2 ratio,0.5269306471901565,,
SR2019_LM2_Biol_repl_3,0.5523020844442499,,
RB2022_4_RecoveryStrength,0.5477258815685973,,
CR2017_Ratio Replicate 2,0.5595092044887957,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,0.556609507346578,,
FSO2013_Ratio H/M normalized Rep3,0.5654903798536273,,
AR2021_KD 72h,0.5307204505714146,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,,0.39476982915547554,0.73128997330148
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,0.5515001723886309,,
KBE2022_Log2_Ex_9_U,,0.39791704369962794,0.7537421438401795
AH2018_SILAC_M_3_N,,,
KBE2022_Log2_Ex_13_T,,0.39108733747911056,0.7444511464799353
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,0.5548309482739221,,
PG2020_Intensity Mock_10h_C,0.5554114835495474,,
CF2017_OSE 29,0.5910195709018409,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,0.5582307975485978,,0.7914122197833017
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,,,
PG2020_Intensity 10h_A,0.5803124361655336,,
RN2012_L12,0.5250275572710095,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,,,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,0.5414134145059661,,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,0.5930864180614878,,
RB2022_7_RecoveryEndurance,0.5516542915999415,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,0.5734250224752777,0.39365111574346856,
TM2022_S2.12h.B,,,
RN2012_L15,0.5496192171430133,,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,0.5849466039495672,,
FSO2013_Ratio H/M normalized Rep2___2,,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,,,0.7432116447327646
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,,,
RB2022_1_PreSprint,0.5493346166618445,,
HS2024_4_I_N1,,,
CK2022_7 200-1,0.605256912337568,,
CK2022_5 200-1,0.6067542109908154,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,0.5529223294134331,,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,0.5538709497690986,,
AH2018_LFQ_2_C,,,
AH2018_SILAC_MR_1_X,,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,0.5511874346054961,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,,,0.7581841611838185
AH2018_SILAC_3_C,,,
EJN2021_5_Rest_Ins,0.5709879052732587,0.3986618841385312,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,0.5408321268373768,,
DB2022_LFQ intensity L2.1,0.5520551585668276,,
FSO2013_Ratio H/M normalized Rep1,0.5397996621453836,,
CK2022_4 16-1,0.5878625480679007,,
AS2011_Ratio H/L,0.5384799570785828,,
SR2019_MCF7_Biol_repl_4,0.5711350587570826,,
EJN2021_2_Ex_Ins,0.5735719627056637,0.39174553198250406,
AS2011_Ratio H/L Inhi_2_3,0.5456645400823803,,
JAW2011_Ratio H/L LS1a_1,0.5615164967019247,,
AH2018_LFQ_1_N,,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,0.5541940871605391,,
JJ2018_Ratio M/L normalized pP2,0.5505815823230025,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,0.5764509117588275,,
FSO2013_Ratio H/L normalized Rep3,0.5637661244640827,,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,0.5351326349537144,,
KTGR2014_Ratio-AA 30 mins,0.5547762612364865,,
JW2021_After_1,0.5493640885535831,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,,
KBE2022_Log2_Ex_9_T,,0.3972269561740423,0.7559852330638686
AH2018_SILAC_IT_2_N,,,
AH2018_SILAC_IT_1_X,,,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,,,
UK2020_UA_2,0.6006432502927335,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,0.5505769122339094,,
WZ2023_Pe_025_20min,0.5960705226086321,,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,0.5400291992866971,,
AH2018_LFQ_2_N,,,
HS2024_4_I_N2,,,
AH2018_TMTMS2_3_N,0.548042497549343,,
RN2012_H06,0.5440670417322343,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),0.5347331860242495,,
HS2024_4_PD_T3,,,
WZ2023_Su_005_30min,0.5990538617372702,,
SR2019_HCC1419_Biol_repl_4,0.5588482250963442,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,0.5740398351020655,,
AS2011_Ratio H/L Protein,0.5520719761582685,,
UK2020_HCM_3,0.5977906889423142,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.5335091199409537,,
WZ2023_Su_025_10min,0.5971610723702683,,
AH2018_LFQ_IT_4_X,,,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,0.544460196796921,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.5950837617813282,,
CW2012_10 µM Gef/control Experiment 1 Replicate B,0.5523275106824119,,
SFR2015_HL_log2_ratio_avg_a,0.5615104229194853,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,0.5527171604932507,,
RB2022_1_PreEndurance,0.551676421041911,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,0.5417270854396189,,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,0.5502053801676775,,
KS2014_Intensity,,,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,0.5594807373152603,,
LY2019_P7+,0.5343266024358594,,
EP2017_Untreated R#1 normalized log2 ratio,0.5208361708756127,,
RN2012_L10,0.5502386397338467,,
PG2020_Intensity 4h_C,0.5655573813879151,,
EP2017_Mitotic R#3 normalized log2 ratio,0.5202003138766786,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,,,0.7530947717733891
RB2022_8_PostStrength,0.5480716822035211,,
AH2018_SILAC_IT_2_X,,,
HS2024_4_B_T3,,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,0.5531848794674126,,
HS2024_8_I_T2,,,
KBE2022_Log2_Ex_6_U,,,0.7278044026122862
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,0.5537304862098895,,
CR2017_Ratio Replicate 1.1,0.5549247847645,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.5901479271734914,,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5405042315529123,,
GF2025_P9_Sph,0.5530322708778679,,
CK2022_6 200-1,0.606098164231752,,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,0.5495941549897266,,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,0.5499055163248959,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,0.5563221399810898,,
HS2024_4_I_T2,,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,0.5567089877748465,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,0.5551698175297828,,
PG2020_Intensity 2h_D,0.5762293300156378,,
EP2017_Untreated R#3 normalized log2 ratio,0.5686664904531303,,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,0.5612325056548829,,
CK2022_8 200-1,0.6057843997827187,,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,0.5515298921576633,,
RB2022_7_PostEndurance,0.5463519621432219,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,0.5528486267487878,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5360298183819449,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),0.5245336922495392,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),0.5606628352987096,,
HS2024_7_I_N1,,,
KBE2022_Log2_Ex_29_T,,0.3909001745550425,0.7507063459548403
HS2024_7_I_T2,,,
AS2011_Ratio H/L Normalized RNAi_2_3,0.5592717778818426,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,0.5546942817456423,,
HS2024_6_B_T2,,,
AMK2021_45I_p5,0.552621671345151,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,0.5598012544769243,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,0.5755448674175763,0.3985792145230413,
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,0.5937316816105521,,
PG2020_Intensity CT_C,0.5658142123376043,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,,,0.7353226708818013
EP2017_Untreated R#3 log2 ratio,0.5689996441631342,,
RB2022_2_PostStrength,0.538175230331812,,
AS2011_Ratio H/L Normalized_1,0.5432309826101681,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,0.563454470342615,,
HS2024_8_PD_T2,,,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,0.5452032706890981,,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,,,0.75758490415304
AS2011_Ratio H/L Normalized Inhi_2,0.5470978126686221,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,0.5482997479217065,,
CR2017_Ratio Replicate 2.3,0.5703043988656515,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),0.5662277040174108,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,0.5589844216828804,,
YA2020_Reporter_intensity_Normal_No.2,,,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,,,
HS2024_3_PD_T3,,,
AMK2021_120R_p3,0.5534779943070025,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,0.5644282946250935,,
AS2011_Ratio H/L Proteins Inhi_1,0.5332223990596239,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,,0.3956958618485975,0.7547663125721025
CK2022_2 16-1,0.5909936522799145,,
RAM2015_Log2 B,0.5601103704764657,,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,0.5725061940048712,0.4051574867443212,
YB2013_Ratio_H_L_Normalized_in_experiment_2,0.5624209431457915,,0.7099788501429039
JJ2018_Ratio H/M normalized pP3___1,0.5575104285468714,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,,
UK2020_HCM_5,0.602974224639758,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,0.5456645400823803,,
DL2023_24h-3,0.5707531719004836,,
HS2024_7_PD_T3,,,
PG2020_Intensity Mock_10h_B,0.5671946474568705,,
WZ2023_Su_025_30min,0.5978145674726549,,
AH2018_LFQ_4_N,,,
CR2017_Ratio Replicate 1.2,0.5408440951916016,,
AS2011_Ratio H/L Normalized by Proteins,0.5267769058034762,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,,,
AMK2021_Ctrl_p3,0.5564623926679357,,
AS2011_Ratio H/L Protein Inhi_2,0.5496522458973748,,
HH2022_Reporter intensity 7,0.5644923181791114,,
AH2018_SILAC_M_1_X,,,
RB2022_7_PreEndurance,0.5497411233886256,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,0.5715173170886618,,
LY2019_P6+,0.5427313808639949,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,0.5528440804252689,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,0.5514241329716989,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),0.5531418859228265,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,0.5468765936226764,,
AS2011_Ratio H/L Inhi_1,0.5306638830815292,,
AS2011_Ratio H/L Normalized RNAi_1_2,0.555713179481552,,
AH2018_TMTMS3_2_C,0.550640656898361,,
SR2019_Hs578T_Biol_repl_4,0.5536647528888143,,
RB2022_8_PreStrength,,,
KS2014_Intensity C5,,,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,0.5616057371076151,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,0.5438985734166375,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,0.5691595531030051,,
GF2025_P9_Adh,0.5616966840641568,,
RB2022_3_PostStrength,,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,,,
SR2019_BT549_Biol_repl_1,0.5638051204423301,,
AH2018_LFQ_M_4_N,,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,0.5727381710674846,,
AH2018_LFQ_2_X,,,
PG2020_Intensity 2h_B,0.5699067915608645,,
AS2011_Ratio H/L Proteins RNAi_1,0.5474002864712694,,
RB2022_4_PostSprint,,,
KS2014_Intensity E15_3,,,
GF2025_P3_Sph,0.5431239814661311,,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.36910305331855625,
AS2011_Ratio H/L RNAi_2_3,0.5494903253405978,,
AH2018_SILAC_IT_1_N,,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,0.5577747922668269,,
RB2022_4_PreEndurance,0.5520330089742663,,
JJ2018_Ratio M/L normalized pP1,0.5393319939398667,,
CR2017_Ratio Replicate 2.4,0.5603756962380535,,
ZQ2022_N1,0.5428647087587644,,
LY2019_P6-,0.5569731911043199,,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,0.6027226358220211,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,0.541128210910387,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,0.5395786178798762,,
AH2018_LFQ_3_N,,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,0.5579949982814145,,
UK2020_UA_1,0.601863635700938,,
KBE2022_Log2_Ex_13_U,,0.3928705763284215,0.7386948096964914
AS2011_Ratio H/L Normalized Inhi_1,0.5304476200313608,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,0.5489857472111813,,
RB2022_1_RecoverySprint,0.5475049613821318,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,0.5518264112281763,,
CK2022_7 40-1,0.590802278305105,,
AS2011_Ratio H/L Inhi_1_3,0.5384411537667452,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,0.5474874353697076,,
JAW2011_Ratio H/L LS1b_1,0.5605503656337912,,
PG2020_Intensity 4h_B,0.5478816012020672,,
SR2019_BT549_Biol_repl_2,0.5583218515115078,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,0.5460645442151175,,
RB2022_5_PostEndurance,0.5443628051451352,,
HS2024_5_PD_T2,,,
WZ2023_Su_025_20min,0.5984677358824249,,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,0.5539159445585958,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,0.5822352542494001,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,0.5372800563065173,,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,0.5716080695455943,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,0.5269503883474342,,
PG2020_Intensity 10h_D,0.5733322270723972,,
RB2022_8_PreEndurance,,,
HS2024_3_B_N2,,,
EJN2021_4_Ex_Ins,0.5766792431854301,0.39646349106272255,
AS2011_Ratio H/L Normalized by Protein,0.5267769058034762,,
EJN2021_1_Ex_Ins,0.5748088903425004,0.39240433062130226,
EP2017_Pervanadate R#3 log2 ratio,0.5317538195519885,,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,0.5557454248468126,,
AH2018_SILAC_MR_3_C,,,
AH2018_LFQ_M_4_C,,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,0.5384411537667452,,
DL2023_12h-1,0.5609643032889734,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,0.5369347413635259,,
CK2022_6 40-1,0.5924389244876569,,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,,,0.7671473287579454
LY2019_P3-,0.5814964197688672,,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,0.5680992671319401,0.3902934645319769,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.5956433956539156,,
HS2024_8_PD_T3,,,
EJN2021_3_Ex_Basal,0.5555618102695903,0.3914791177636449,
AST2020_Control.1,0.5625044688985886,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,0.5675938112837516,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.5994789651855145,,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,0.5538973695776717,,
GF2025_P10_Adh,0.5910227740621531,,
RB2022_1_RecoveryStrength,0.5474988000957758,,
SR2019_HCC1954_Biol_repl_4,0.5499685653862472,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,0.5492122857885071,,
RB2022_4_PreSprint,0.5499133111084294,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,0.5480872563375635,,
HS2024_8_I_N2,,,
RB2022_3_RecoveryStrength,,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,,,
LY2019_P8+,0.5464421267696506,,
RB2022_2_RecoveryEndurance,0.5521998621594603,,
JJ2018_Ratio H/M normalized pP2___1,0.5590337423997909,,
JAW2011_Ratio H/L HS_1,0.5610377987007974,,
RB2022_3_PostEndurance,0.549932240531171,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,0.5698949506922385,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.3786788475445106,
AS2011_Ratio H/L Normalized RNAi_1_1,0.5434437721796465,,
AH2018_LFQ_M_4_X,,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,0.5490889202296284,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,,,0.7460452299908131
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,0.6073979555986827,,
LY2019_P2-,0.5582903093723257,,
AH2018_LFQ_IT_1_X,,,
JJ2018_Ratio H/L normalized pP3___1,0.5517557887189349,,
RB2022_8_RecoveryStrength,0.5571072237533157,,
WZ2023_Pe_005_20min,0.5996932164172438,,
AST2020_Control.2,0.5626535740407348,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,0.525755462886578,,
HS2024_3_I_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,0.5907753462437294,,
SR2019_MCF10A_Biol_repl_4,0.5653050551704678,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,0.6050414882298255,,
HS2024_5_B_T2,,,
HS2024_6_I_T1,,,
HS2024_5_B_T3,,,
JJ2018_Ratio H/M normalized pP1___1,0.5665754000615424,,
KBE2022_Log2_Ex_36_U,,0.4072635546893644,0.7518439976672546
AH2018_TMTMS3_3_N,0.5489290949007151,,
SR2019_HCC1419_Biol_repl_2,0.5545893819058965,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,0.5261790711617189,,
KBE2022_Log2_Ex_36_T,,0.40575756858131173,0.764688696551941
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.5993239335584033,,
KS2014_Intensity C2,,,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,,,0.7690989580300578
CK2022_9 200-1,0.6125919476934347,,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,0.5511641736685098,,
CK2022_10 200-1,0.6158410499588327,,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,,
RBK2021_1332T Late,,,
LY2019_P1-,0.548775035006367,,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,0.5619673672695785,,
HS2024_3_I_T3,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,0.5621361555294341,,
KS2014_Intensity E15_4,,,
ZQ2022_C3,0.5459140682210157,,
EJN2021_3_Rest_Ins,0.5739932339469334,0.39811277184877936,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,,,0.7413668147474325
FSO2013_Ratio H/M normalized Rep3___2,,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,0.5209759809289639,,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.596583298083753,,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,0.5545574596267692,,
HS2024_5_I_T3,,,
KS2014_Intensity N1,,,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.5505500857187869,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),0.5415598252805376,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,0.5575397697932836,,
AH2018_SILAC_MR_2_C,,,
LATM2013_Log2 Ratio (Medium/Light) Forward,0.5542066567946252,,
PG2020_Intensity 2h_A,0.5616623045295669,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,,,
JJ2018_Ratio H/M normalized___1,0.5709890581073007,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,0.5306281925383685,,
RN2012_H03,0.5239737124846783,,
HS2024_5_B_N2,,,
HS2024_5_I_N1,,,
HS2024_6_I_N1,,,
AR2021_KD 48h,0.5225908136434017,,
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,0.5462242369435968,,
HS2024_5_I_T1,,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,0.5540205900433876,,
AST2020_anti-CD3,0.5630643625872773,,
SR2019_MDAMB231_Biol_repl_1,0.5550210417440389,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.5975585285646194,,
KBE2022_Log2_Ex_29_U,,0.3985210909910925,0.7517988674069854
HS2024_7_B_T1,,,
AH2018_LFQ_M_2_X,,,
AH2018_LFQ_IT_4_N,,,
CK2022_15 200-1,0.5926300490208303,,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,0.5705904360085076,,
JJ2018_Ratio M/L normalized pP3___1,0.5483485639626126,,
KBE2022_Log2_Ex_34_T,,,0.7560027443361825
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,0.555491360003434,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,0.5542244768789196,,
CK2022_2 200-1,0.6108087781801311,,
AS2011_Ratio H/L Protein RNAi_2,0.5576015135276533,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.5962845561198195,,
RN2012_H01,0.5567762428109964,,
KTGR2014_Ratio-Rapa 2 mins,0.5581918153822831,,
EJN2021_2_Rest_Basal,0.5744307319139271,0.401938138456105,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,0.5593285248839687,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5419789789013364,,
HS2024_8_B_T3,,,
YA2020_Reporter_intensity_Cancer_No.3,,,
KBE2022_Log2_Ex_44_U,,,0.7444379670192718
WZ2023_Pe_010_20min,0.5985839041756732,,
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,0.5480895991261202,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,0.40519015232346645,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,,,
FSO2013_Ratio H/M normalized Rep3___1,0.5654248914021464,,
AH2018_SILAC_M_3_C,,,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,,,
AH2018_SILAC_M_2_X,,,
KTGR2014_Ratio-Rapa 15 mins,0.5501901153948072,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,,,0.7481624531005575
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.5973244453944405,,
PG2020_Intensity 6h_C,0.5729104678605068,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,0.5535062095762285,,
JJ2018_Ratio M/L normalized pP1___1,0.5388971068285788,,
AH2018_LFQ_M_3_N,,,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,0.5506253312059912,,
CK2022_15 16-1,0.5718777084684601,,
CK2022_3 16-1,0.5900510592080448,,
LY2019_P4-,0.5266625309512782,,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,,,
GF2025_P8_Adh,0.5642000783104054,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,0.5047658529824643,,
CK2022_10 16-1,0.5956612021765929,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,0.551166759295455,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.4304553488275899,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,0.5498879304478874,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,0.5430856053053245,,
UK2020_HCM_4,0.6019322185753291,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,0.5494628937472873,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,0.5567448723475539,,
EP2017_Mitotic R#1 log2 ratio,0.5448149296968916,,
EJN2021_2_Ex_Basal,0.570466321564691,0.39896477816250514,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),0.5542485544797169,,
KTGR2014_Ratio-Rapa 30 mins,0.5642796579735958,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,0.5923580439871104,,
AR2021_L41 10 μM,0.5306644218175158,,
CF2017_EOC 2,0.621864107528504,,
RB2022_6_PostEndurance,0.5466306462706038,,
AH2018_SILAC_1_N,,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,0.5953167101352095,,
RB2022_7_PreSprint,0.5531395081969757,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,,
CK2022_6 16-1,0.5903844091884558,,
ZX2022_CB treated Replicate 1,0.5477636481043318,,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,0.5573025420234328,0.3943328005792202,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,0.551165538366403,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,0.5496739057900755,,
AR2021_L41 1 μM,0.570704283609381,,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,0.5513913662949246,,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,0.5519356217169162,,
ZX2022_Control Replicate 3,0.5512999635554604,,
KS2014_Intensity C4,,,
AS2011_Ratio H/L Inhi_2,0.5470058952553756,,
KBE2022_Log2_Ex_18_T,,0.39034274836462896,0.7437302264289376
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,0.5709868967096656,,
HS2024_7_B_T2,,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,0.5509850035953165,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,,,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,,
AH2018_SILAC_IT_3_C,,,
WZ2023_Pu_025_10min,0.6017144403958553,,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,0.5496099007613484,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,0.5528828566145476,,
SR2019_JIMT1_Biol_repl_4,0.5689532695040809,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,0.6026252160396972,,
JJ2018_Ratio H/L normalized pP1___1,0.5504221857222676,,
WZ2023_Pe_010_30min,0.597715432103591,,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,,
KS2014_Intensity C6,,,
ZQ2022_N3,0.5495260841709111,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,0.5791669358544459,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,0.5538960296195212,,
JJ2018_Ratio H/M normalized pP1,0.5663082230418973,,
CK2022_16 40-1,0.5683434632117371,,
AH2018_SILAC_IT_2_C,,,
CK2022_5 40-1,0.5934608007441348,,
AH2018_LFQ_3_X,,,
UK2020_UA_3,0.5978115550792957,,
LY2019_P7-,0.5742739243486934,,
GF2025_P5_Adh,0.5332194173136835,,
RB2022_1_PostStrength,0.5459311320278243,,
JAW2011_Ratio H/L LS1b,0.5605503656337912,,
FSO2013_Ratio H/L normalized Rep3___1,0.5639988408742127,,
SR2019_HCC1954_Biol_repl_3,0.5587575299122491,,
CR2017_Ratio Replicate 2.2,0.5515045209182614,,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,0.5497907006360772,,
CK2022_11 16-1,0.5912206471488979,,
ZQ2022_C1,0.5566389169283634,,
CR2017_Ratio Replicate 2.1,0.5558640447611753,,
PG2020_Intensity CT_B,0.558444453182239,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,0.5633886841596774,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,0.4038111292037818,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,0.5608199944127852,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,0.5521269525069241,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,,,
YA2020_Reporter_intensity_Cancer_No.4,,,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,0.5181678838054335,,
RB2022_2_PreEndurance,0.5568593274011161,,
JW2021_Before_1,0.5545607529596243,,
KBE2022_Log2_Ex_25_T,,,0.7635500493665179
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,0.5349177881080395,,
FR2021_Intensity.H,,,
CK2022_14 16-1,0.5705747895597253,,
AST2020_anti-CD3+PDL2,0.5631008367289095,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,,,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,,,
HS2024_8_I_T1,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,0.39576389135855683,
EP2017_Mitotic R#2 log2 ratio,0.5376016764105516,,
AH2018_TMTMS2_1_X,,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,0.5608091835583571,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,0.555713179481552,,
SR2019_MCF10A_Biol_repl_1,0.568891444635695,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,0.5716421314660748,0.39120982811081045,
HS2024_6_I_N2,,,
HH2022_Reporter intensity 4,0.5624565812730519,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,0.6059149484282703,,
HS2024_4_I_T3,,,
AH2018_SILAC_1_X,,,
PG2020_Intensity 10h_B,0.5857397610262381,,
AH2018_TMTMS3_1_X,0.5502600785918723,,
CF2017_FTE 14,0.5942543854482804,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,0.5685446611597643,,
SR2019_HCC1419_Biol_repl_3,0.5549397974793044,,
KBE2022_Log2_Ex_14_T,,0.39711256184270577,0.7438428258336155
EP2017_Untreated R#2 normalized log2 ratio,0.5267324873059326,,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,0.5357896150407939,,
HS2024_5_I_N2,,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,0.5358505553559217,,
AS2011_Ratio H/L Normalized RNAi_2_1,0.5494903253405978,,
